Gino is joined by James Rickard, Chief Scientific Officer of Biotherapy Services.

James, a former Deputy Chief Pharmacist at The Royal London Hospital, has been developing new therapies that will allow pharmacists to successfully treat difficult wounds, such as diabetic leg ulcers.

They discuss these new treatments, their remarkable results, and how pharmacists will be central to administering them.

Hosted on Acast. See acast.com/privacy for more information.

Gino is joined by RPS CEO Paul Bennett, and the two of them talk to Ian McCubbin OBE, Manufacturing Advisor for the UK Vaccine Taskforce, and former Senior Vice President for Global Manufacturing and Supply at GlaxoSmithKline.

Ian shares his observations on a long and distinguished career in pharmacy, and more recently on being at the heart of the pandemic response.

Hosted on Acast. See acast.com/privacy for more information.

In this episode, Gino talks to David Hipkiss, CEO of Enesi Pharma, about developments in solid dose formulation and needle-free delivery for vaccines.

Vaccines have come under unprecedented scrutiny during the pandemic, and the two look at ways in which these new technologies could dramatically change the way we store vaccines and deliver them in future.

Hosted on Acast. See acast.com/privacy for more information.